Masimo Overview
- Year Founded
-
1989
- Status
-
Public
- Employees
-
3,796
- Stock Symbol
-
MASI
- Investments
-
15
- Share Price
-
$165.57
- (As of Monday Closing)
Masimo General Information
Description
Masimo Corp is a global technology company. The company's segment includes healthcare and non-healthcare. The healthcare business segment is a key revenue driver, develops, manufactures, and markets a variety of noninvasive patient monitoring technologies, hospital automation and connectivity solutions, remote monitoring devices and consumer health products. Its non-healthcare segment includes consumer audio business develops, manufactures, markets sells and licenses premium and luxury audio sound products and related integration technologies.
Contact Information
Website
www.masimo.comCorporate Office
- 52 Discovery
- Irvine, CA 92618
- United States
Corporate Office
- 52 Discovery
- Irvine, CA 92618
- United States
Masimo Stock Performance
As of 13-Jan-2025, Masimo’s stock price is $165.57. Its current market cap is $8.91B with 53.5M shares.
(As of Monday Closing)
Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
---|---|---|---|---|---|---|
$165.57 | $166.42 | $101.61 - $180.97 | $8.91B | 53.5M | 545K | $1.48 |
Masimo Financials Summary
As of 30-Sep-2024, Masimo has a trailing 12-month revenue of $2.04B.
In Thousands, USD |
TTM 30-Sep-2024 | FY 2023 31-Dec-2023 | FY 2022 31-Dec-2022 | FY 2021 31-Dec-2021 |
---|---|---|---|---|
EV | 7,863,070 | 7,068,524 | 8,595,642 | 15,549,070 |
Revenue | 2,042,600 | 2,048,100 | 2,035,800 | 1,239,200 |
EBITDA | 242,400 | 253,000 | 353,400 | 309,900 |
Net Income | 78,600 | 81,500 | 143,500 | 229,600 |
Total Assets | 3,087,800 | 3,041,500 | 3,210,600 | 1,887,000 |
Total Debt | 860,900 | 970,000 | 1,028,800 | 32,700 |
Masimo Valuation & Funding
Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
---|
Masimo Cap Table
Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price |
% Owned |
---|
Masimo Comparisons
Industry
Financing
Details
Masimo Competitors (12)
One of Masimo’s 12 competitors is iRhythm Technologies, a Formerly VC-backed company based in San Francisco, CA.
Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
---|---|---|---|---|---|---|
iRhythm Technologies | Formerly VC-backed | San Francisco, CA | ||||
Edwards Lifesciences | Corporation | Irvine, CA | ||||
Philips | Corporation | Amsterdam, Netherlands | ||||
Nihon Kohden | Corporation | Tokyo, Japan | ||||
Drägerwerk | Corporation | Lubeck, Germany |
Masimo Patents
Masimo Recent Patent Activity
Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
---|---|---|---|---|---|
US-20240404549-A1 | Auditory health monitoring system with auricular device and physiological sensor | Pending | 02-Jun-2023 | ||
US-20240380246-A1 | Induction charger | Pending | 10-May-2023 | ||
US-20240380247-A1 | Induction charger | Pending | 10-May-2023 | ||
US-20240324953-A1 | Opioid overdose detection using pattern recognition | Pending | 03-Apr-2023 | ||
US-20240298920-A1 | Systems and methods for monitoring respiratory gases | Pending | 08-Mar-2023 | A61B5/082 |
Masimo Signals
Masimo Investors
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
---|
Masimo Investments & Acquisitions (15)
Masimo’s most recent deal was a Merger/Acquisition with Nura. The deal was made on 06-Apr-2023.
Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
---|---|---|---|---|---|
Nura | 06-Apr-2023 | Merger/Acquisition | Electronics (B2C) | ||
Sound United | 11-Apr-2022 | Merger/Acquisition | Electronics (B2C) | ||
NeurAxis | 29-Mar-2021 | Later Stage VC | Therapeutic Devices | ||
LiDCO Group | 01-Dec-2020 | Merger/Acquisition | Therapeutic Devices | ||
TNI Medical | 28-Mar-2020 | Merger/Acquisition | Therapeutic Devices |
Masimo ESG
Risk Overview
Risk Rating
Updated May, 31, 2024
31.28 | High Risk
Risk Scale
A lower score indicates better sustainability
Negl
0-10
Low
10-20
Med
20-30
High
30-40
Severe
40+
Exposure
Exposure refers to the extent to which a company is exposed to different material ESG issues
Management
Management is related to actions taken to manage ESG issues
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
of 15,104
Rank
Percentile
Healthcare
Industry
of 588
Rank
Percentile
Medical Devices
Subindustry
of 200
Rank
Percentile
Masimo Exits (1)
Masimo’s most recent exit was on 29-Mar-2021 from NeurAxis. The exit was categorized as with 2 buyers.
Company Name | Exit Date | Exit Type | Exit Size | Status | Buyers |
---|---|---|---|---|---|
NeurAxis | 29-Mar-2021 | Completed |
|
Affiliates
Subsidiaries (4)
Name | Industry | Location | Year Founded |
---|---|---|---|
Nura | Brunswick, Australia | 2015 | |
TNI Medical | Wurzburg, Germany | 2007 | |
Masimo (Audio And Consumer Health Businesses) | Irvine, CA | ||
Masimo Semiconductor | Hudson, NH |
Masimo FAQs
-
When was Masimo founded?
Masimo was founded in 1989.
-
Where is Masimo headquartered?
Masimo is headquartered in Irvine, CA.
-
What is the size of Masimo?
Masimo has 3,796 total employees.
-
What industry is Masimo in?
Masimo’s primary industry is Monitoring Equipment.
-
Is Masimo a private or public company?
Masimo is a Public company.
-
What is Masimo’s stock symbol?
The ticker symbol for Masimo is MASI.
-
What is the current stock price of Masimo?
As of 13-Jan-2025 the stock price of Masimo is $165.57.
-
What is the current market cap of Masimo?
The current market capitalization of Masimo is $8.91B.
-
What is Masimo’s current revenue?
The trailing twelve month revenue for Masimo is $2.04B.
-
Who are Masimo’s competitors?
iRhythm Technologies, Edwards Lifesciences, Philips, Nihon Kohden, and Drägerwerk are some of the 12 competitors of Masimo.
-
What is Masimo’s annual earnings per share (EPS)?
Masimo’s EPS for 12 months was $1.48.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »